Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

How New Therapies Are Reshaping HER2+ Breast Cancer

Once a uniformly aggressive subtype, HER2+ breast cancer is now a proving ground for the most innovative therapies in oncology.

Deep Dive: Treatment or Surgery First in Pancreatic Cancer?

Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it.

Fecal Transplant Offers No Clear Benefit in IBS

Fecal microbiota transplantation offers no clear benefit in reducing symptoms of irritable bowel syndrome, a meta-analysis finds.

Should Type 2 Patients Not on Insulin Use Glucose Monitors?

While research shows some blood glucose benefits, perhaps the biggest benefit comes from lifestyle changes.

AAP Guidance Seeks to Prevent Iron Deficiency Anemia

The new recommendations include universal screening for teens girls, who are at a high risk for iron deficiency and iron deficiency anemia.

PSMA-PET-CT May Allow Some Men to Skip Prostate Biopsy

Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer follow-up is needed.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

Once a uniformly aggressive subtype, HER2+ breast cancer is now a proving ground for the most innovative therapies in oncology.

Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it.

Fecal microbiota transplantation offers no clear benefit in reducing symptoms of irritable bowel syndrome, a meta-analysis finds.

While research shows some blood glucose benefits, perhaps the biggest benefit comes from lifestyle changes.

The new recommendations include universal screening for teens girls, who are at a high risk for iron deficiency and iron deficiency anemia.

Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer follow-up is needed.

News All Time

Micro- and Nanoplastics: A Multiorgan Health Threat

Once present in the body, microplastics and nanoplastics can disrupt biological barriers and contribute to diseases impacting the gastrointestinal system and beyond.

Nasal Strips: Fancy Tape or Medical Miracle?

Nasal strips flood your feed and promise better sleep. Dr Labos investigates whether nasal strips are worth the hype — or just a very convincing placebo.

Deep Dive: Is Bariatric Surgery Over?

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Parkinson’s Treatment: Are Dopamine Agonists Fading?

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor benefits against behavioral side effects.

Does Liso-Cel Offer Long-Term Survival Benefits in R/R LBCL?

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or refractory LBCL in the TRANSCEND study.

Treat or Wait, New Data on Asymptomatic Kidney Stones

Actively treating asymptomatic kidney stones is associated with lower odds of later recurrence and the need for surgery.

Australia’s New Lung Cancer Screening Enjoys High Uptake

The first year of Australia’s lung cancer screening program appears to be a success, with high uptake among its target population of heavy smokers.

Prostate Care: Quick Relief vs Retreatment

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.
HTTP error: 503HTTP error: 503HTTP error: 503

Trofinetide Approved for Rett Syndrome After Reexamination

The EMA reverses its previous decision and grants marketing authorization to the world’s first drug specifically approved for treating the syndrome.

Pfizer Trial Backs Paxlovid Dose for High-Risk Children

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

New Parkinson’s Drug Combines Immediate and Slow Release

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.
HTTP error: 503

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Better treatments buoy multiple-myeloma patients, bound by research cuts and racial disparities

2.

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

3.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

4.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

5.

For treatment, the majority of cancer patients choose complementary therapies.

1.

Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections

2.

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology

3.

Uncovering the Mysteries of Breast Cancer: The Journey to a Cure

4.

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide

5.

Adaptive Rehabilitation Strategies for Advanced Cancer Survivorship

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot